Century Therapeutics, Inc. logo

Century Therapeutics, Inc.

NASDAQ:IPSC

Overview | Financials
Company Name Century Therapeutics, Inc.
Symbol IPSC
Currency USD
Price 1.26
Market Cap 106,742,160
Dividend Yield 0%
52-week-range 1.14 - 5.51
Industry Biotechnology
Sector Healthcare
CEO Dr. Gregory Russotti Ph.D.
Website https://www.centurytx.com

An error occurred while fetching data.

About Century Therapeutics, Inc.

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also

Related Stocks

Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc.

CRBU

2.21 USD

ANI Pharmaceuticals, Inc. logo

ANI Pharmaceuticals, Inc.

ANIP

58.19 USD

Aura Biosciences, Inc. logo

Aura Biosciences, Inc.

AURA

10.15 USD

Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc.

TNGX

5.15 USD

Inhibrx, Inc. logo

Inhibrx, Inc.

INBX

15.8 USD

Cullinan Oncology, Inc. logo

Cullinan Oncology, Inc.

CGEM

15.78 USD

Geron Corporation logo

Geron Corporation

GERN

4.11 USD

Financials

Numbers are in millions USD

Numbers are in millions USD